REGENXBIO Inc. (RGNX)

REGENXBIO Revenue

REGENXBIO had revenue of $108.02M in the quarter ending June 30, 2026, with 405.73% growth. This brings the company's total for the last twelve months to $174.48M, up 12.00% year-over-year. In the year 2025, REGENXBIO had annual revenue of $170.44M with 104.54% growth. That makes REGENXBIO the 18,459th largest company in the world by revenue and 2,956th in the United States.

• Revenue (ttm): $174.48M
• Revenue Growth: +12.00%
• P/S Ratio: 2.91
• Revenue / Employee: $470,302
• Employees: 371
• Market Cap: 500.38M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 74.99M 44.0%
• Foreign 52.84M 31.0%
• United States 42.61M 25.0%

Fiscal year ended Dec 31, 2025 See the full REGENXBIO breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	170.44M	87.11M	104.54%
Dec 31, 2024	83.33M	-6.91M	-7.66%
Dec 31, 2023	90.24M	-22.48M	-19.94%
Dec 31, 2022	112.72M	-357.62M	-76.03%
Dec 31, 2021	470.35M	315.78M	204.30%
Dec 31, 2020	154.57M	119.33M	338.70%
Dec 31, 2019	35.23M	-183.27M	-83.88%
Dec 31, 2018	218.51M	208.11M	2,002.42%
Dec 31, 2017	10.39M	5.80M	126.48%
Dec 31, 2016	4.59M	-3.00M	-39.52%
Dec 31, 2015	7.59M	1.47M	23.99%
Dec 31, 2014	6.12M	33.00K	0.54%
Dec 31, 2013	6.09M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error